The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Research works printed but not linked: 15
- Bianco, 2001, Bone marrow stromal stem cells, Stem Cells, 19, 180, 10.1634/stemcells.19-3-180 · DOI · Paper page
- Bonnotte, 2001, Identification of tumor-infiltrating macrophages as the killers of tumor cells after immunization in a rat model system, J. Immunol., 167, 5077, 10.4049/jimmunol.167.9.5077 · DOI
- Brodin, 1989, Use of a monoclonal rat anti-mouse Ig light chain (RAMOL-1) antibody reduces background binding in immunohistochemical and fluorescent antibody analysis, J. Histochem. Cytochem., 37, 1013, 10.1177/37.7.2499618 · doi:10.1177/37.7.2499618
- Brunner, 1992, Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta 1 (TGF beta 1) and TGF beta 2 (414) precursors and of cysteine residues within mature TGF beta 1, Mol. Endocrinol., 6, 1691, 10.1210/me.6.10.1691 · DOI
- Cannons, 2001, 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy, J. Immunol., 167, 1313, 10.4049/jimmunol.167.3.1313 · DOI · Paper page
- Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
- Hansen, 1989, Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill, J. Immunologic. Methods., 119, 203, 10.1016/0022-1759(89)90397-9 · DOI · Paper page
- Hegardt, 2001, Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma, Cancer Immunol. Immunother., 50, 491, 10.1007/s002620100230 · DOI
- Hellström, 1990, Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens, Cancer Res., 50, 2183
- Javazon, 2001, Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells, Stem Cells, 19, 219, 10.1634/stemcells.19-3-219 · DOI · Paper page
- Luster, 1998, Chemokines—chemotactic cytokines that mediate inflammation, N. Engl. J. Med., 338, 436, 10.1056/NEJM199802123380706 · DOI · Paper page
- Mackenzie, 2001, Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep, Blood Cells Mol. Dis., 27, 601, 10.1006/bcmd.2001.0424 · DOI
- Minguell, 2001, Mesenchymal stem cells, Exp. Biol. Med. (Maywood), 226, 507, 10.1177/153537020122600603 · DOI · Paper page
- Schiött, 2000, Effects of transforming growth factor betal expression in a rat colon carcinoma, Cancer Immunol. Immunother., 48, 579, 10.1007/PL00006676 · doi:10.1007/pl00006676
- Visse, 2000, Immunohistochemical analysis of glioma-infiltrating leucocytes after peripheral therapeutic immunization with interferon-gamma-transfected glioma cells, Cancer Immunol. Immunother., 49, 142, 10.1007/s002620050613 · doi:10.1007/s002620050613
Cited by
Ding, D.-C., Shyu, W.-C., & Lin, S.-Z. (2011) · Cell Transplantation · doi:10.3727/096368910x · Cited by 894
Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M., & Marini, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004992 · Cited by 807
Klopp, A. H., Gupta, A., Spaeth, E., Andreeff, M., & Marini, F. (2011) · Stem Cells · doi:10.1002/stem.559 · Cited by 562
Le Blanc, K., & Ringdén, O. (2005) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2005.01.005 · Cited by 471
Frenette, P. S., Pinho, S., Lucas, D., & Scheiermann, C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095919 · Cited by 462
CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers
Burger, J. A., & Peled, A. (2009) · Leukemia · doi:10.1038/leu.2008.299 · Cited by 462
Mesenchymal stem cells: a new strategy for immunosuppression?
Uccelli, A., Pistoia, V., & Moretta, L. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.03.001 · Cited by 461
Ramasamy, R., Lam, E. W.-F., Soeiro, I., Tisato, V, Bonnet, D., & Dazzi, F. (2007) · Leukemia · doi:10.1038/sj.leu.2404489 · Cited by 404
Mesenchymal stem cells: the fibroblasts' new clothes?
Haniffa, M. A., Collin, M. P., Buckley, C. D., & Dazzi, F. (2009) · Haematologica · doi:10.3324/haematol.13699 · Cited by 345
Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1
Zhu, Y., Sun, Z., Han, Q., Liao, L., Wang, J., Bian, C., Li, J., Yan, X., Liu, Y., Shao, C., et al. (2009) · Leukemia · doi:10.1038/leu.2008.384 · Cited by 338
Tumor microenvironment promotes breast cancer chemoresistance
Mehraj, U., Dar, A. H., Wani, N. A., & Mir, M. A. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04222-w · Cited by 289
Concise Review: Adult Multipotent Stromal Cells and Cancer: Risk or Benefit?
Lazennec, G., & Jorgensen, C. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1006 · Cited by 255
Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model
Sun, B., Roh, K.-H., Park, J.-R., Lee, S.-R., Park, S.-B., Jung, J.-W., Kang, S.-K., Lee, Y.-S., & Kang, K.-S. (2009) · Cytotherapy · doi:10.1080/14653240902807026 · Cited by 214
Mesenchymal stroma: Role in osteosarcoma progression
Cortini, M., Avnet, S., & Baldini, N. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.024 · Cited by 171
Mesenchymal Stem Cells in Cancer: Tumor-Associated Fibroblasts and Cell-Based Delivery Vehicles
Hall, B., Dembinski, J., Sasser, A., Studeny, M., Andreeff, M., & Marini, F. (2007) · International Journal of Hematology · doi:10.1532/ijh97.06230 · Cited by 171
Mesenchymal stem cell secretome and regenerative therapy after cancer
Zimmerlin, L., Park, T. S., Zambidis, E. T., Donnenberg, V. S., & Donnenberg, A. D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.010 · Cited by 168
The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe
Kidd, S., Spaeth, E., Klopp, A., Andreeff, M., Hall, B., & Marini, F. (2008) · Cytotherapy · doi:10.1080/14653240802486517 · Cited by 128
Potential implications of mesenchymal stem cells in cancer therapy
Dai, L.-J., Moniri, M. R., Zeng, Z.-R., Zhou, J. X., Rayat, J., & Warnock, G. L. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.02.012 · Cited by 99
“Additional evidence for tumor suppression of MSCs was presented by the inhibition of outgrowth of rat colon carcinoma cells upon subcutaneous co-transplantation in a gelatin matrix [102].”
BackgroundYe, H., Cheng, J., Tang, Y., Liu, Z., Xu, C., Liu, Y., & Sun, Y. (2012) · Cancer Investigation · doi:10.3109/07357907.2012.692171 · Cited by 78
Slama, Y., Ah-Pine, F., Khettab, M., Arcambal, A., Begue, M., Dutheil, F., & Gasque, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713511 · Cited by 57
Influence of mesenchymal stem cells on metastasis development in mice in vivo
Meleshina, A. V., Cherkasova, E. I., Shirmanova, M. V., Klementieva, N. V., Kiseleva, E. V., Snopova, L. В., Prodanets, N. N., & Zagaynova, E. V. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0003-7 · Cited by 45
Yang, L., Zhang, Y., Cheng, L., Yue, D., Ma, J., Zhao, D., Hou, X., Xiang, R., & Cheng, P. (2016) · Human Gene Therapy · doi:10.1089/hum.2015.135 · Cited by 39
“43,44 Therefore, we suggest that patients treated with MSCs should be followed because the potential side effects of immunosuppression induced by MSCs cannot be ignored.”
Afkhami, H., Mahmoudvand, G., Fakouri, A., Shadab, A., Mahjoor, M., & Komeili Movahhed, T. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1255697 · Cited by 27
LEE, S.-W., JEON, T. J., & BISWAL, S. (2015) · Oncology Reports · doi:10.3892/or.2015.3711 · Cited by 10
Metadata
- Authors
- Ohlsson, L. B., Varas, L., Kjellman, C., Edvardsen, K., & Lindvall, M.
- Venue
- Experimental and Molecular Pathology
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 75
- Issue
- 3
- Pages
- 248-255
- ISSN
- 0014-4800 (ISSN-L)
- OpenAlex
- W2017969565
- Cited by
- 182
- References
- 1
- FWCI
- 0.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.